Similar findings have emerged in the context of metabolic syndrome, where significantly higher irisin concentrations were reported in comparison to healthy controls [71], giving rise to the theory of irisin resistance in metabolically-compromised individuals [72]. The gene discussed is FNDC5; the disease is metabolic syndrome.